Therapy: The role of liquid biopsies to manage and predict PRRT for NETs. (Q54120525)

25 May 2018

title

Therapy: The role of liquid biopsies to manage and predict PRRT for NETs. (English)

1 reference

25 May 2018

0 references

Mark Kidd

1

1 reference

25 May 2018

Irvin M Modlin

series ordinal

2

1 reference

25 May 2018

language of work or name

English

0 references

publication date

15 March 2017

1 reference

25 May 2018

Nature Reviews Gastroenterology & Hepatology

published in

1 reference

25 May 2018

volume

14

1 reference

25 May 2018

issue

6

1 reference

25 May 2018

page(s)

331-332

1 reference

25 May 2018

https://scigraph.springernature.com/pub.10.1038/nrgastro.2017.26

exact match

0 references

cites work

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

Consensus on biomarkers for neuroendocrine tumour disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

Everolimus for advanced pancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

The identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.26

21 January 2018

Identifiers

DOI

10.1038/NRGASTRO.2017.26

1 reference

25 May 2018

Dimensions Publication ID

0 references

1 reference

25 May 2018